The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Company Secretary, Issue of Equity

22 Jul 2019 16:56

RNS Number : 3303G
Craven House Capital PLC
22 July 2019
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Craven House Capital plc

 

("Craven House" or the "Company")

 

Change of Company Secretary, Issue of Equity

 

 

Craven House Capital (AIM:CRV) announces the appointment of Ms. Tamra Spink as Company Secretary. Her predecessor, Mr. Brian Winters has stepped down from the role with effect from today.

 

The Company has allotted 14,400 ordinary shares of $1.00 in the capital of the Company ("Ordinary Shares") at a price of $12.50 per share to Mr. Brian Winters as settlement for company secretarial services provided by him since August 2016.

 

Application will be made for the admission to trading on AIM ("Admission") for the 14,400 new Ordinary Shares. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company. Admission is expected at 8.00 a.m. on or around 26 July 2019.

 

Total Voting Rights

 

Following Admission, the Company's issued share capital will comprise 2,513,438 Ordinary Shares which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury.

 

 

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel: 0203 368 3550

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Mr Brian Winters

2

Reason for the notification

a)

Position/status

Company Secretary

b)

Initial notification / Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Craven House Capital Plc

b)

Legal Entity Identifier

 2138008MJUBUX6WX9B72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of $1.00 each

 

 

 

GB00BD4FQ360

b)

Nature of the transaction

Issue of shares as part of salary

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

$12.50

14,400

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 N/A single transaction

 

f)

Date of the transaction

 22 July 2019

g)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFEEDFIFFIA
Date   Source Headline
26th Sep 20072:00 pmRNSTrading Statement
10th Aug 20077:01 amRNSAIM Rule 26
21st Jun 20077:01 amRNSJoint Venture
19th Jun 20073:52 pmRNSIssue of Warrants
14th Jun 200711:37 amRNSResult of AGM
14th Jun 20077:01 amRNSAGM Statement
31st May 20071:00 pmRNSTotal Voting Rights
31st May 200712:30 pmRNSIssue of Equity
31st May 200712:00 pmRNSRelated Party Transactions
25th Apr 20072:42 pmRNSTrading Update
11th Apr 200711:20 amRNSHolding(s) in Company
22nd Mar 20077:02 amRNSFinal Results
19th Mar 20078:00 amRNSNotice of Results
11th Dec 200611:51 amRNSTotal Voting Rights
26th Oct 20067:01 amRNSProperty Development
27th Sep 20067:01 amRNSInterim Results
31st Jul 20067:01 amRNSSaga Contract
10th Jul 20067:00 amRNSItalian Contract Update
4th Jul 200610:58 amRNSChange of Adviser
16th Jun 20064:13 pmRNSResult of AGM
16th Jun 20067:00 amRNSAGM Statement
17th May 20067:00 amRNSReport and Accounts Posted
25th Apr 20062:48 pmRNSProgress in First Quarter
6th Apr 20066:24 pmRNSDirector/PDMR Shareholding
6th Apr 20068:00 amRNSPreliminary Results
22nd Feb 20063:46 pmRNSShare price movement
16th Dec 200512:25 pmRNSChange of Registered Office
23rd Nov 20057:00 amRNSExpansion into Cyprus, Turkey
28th Oct 20058:00 amRNSBusiness Update
29th Sep 20054:47 pmRNSInterim Results
4th Jul 20057:00 amRNSProperty Development
15th Jun 200511:00 amRNSAGM Statement
20th May 200512:59 pmRNSAnnual Report and Accounts
16th May 20059:00 amRNSBusiness Update
21st Apr 200512:42 pmRNSTrading Statement
21st Mar 20059:38 amRNSFinal Results
3rd Mar 20054:39 pmRNSNotice of Prelimnary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.